These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17341168)

  • 1. Neuronal and myelin reactive humoral immunity in multiple sclerosis is Th2 dependent.
    Qin Y; van den Noort S
    Expert Rev Neurother; 2007 Mar; 7(3):219-20. PubMed ID: 17341168
    [No Abstract]   [Full Text] [Related]  

  • 2. Myelin-basic protein-reactive specific CD4+ and CD8+ NK lymphocytes induce morphological changes in neuronal cell bodies and myelin sheaths: implications for multiple sclerosis.
    Zhang QY; Huang JH; Li HZ; Guo HT; Zhong YQ; Wang YM; Pei JM
    Arch Med Res; 2008 Jan; 39(1):45-51. PubMed ID: 18067995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Myelin antibodies].
    Aarli JA
    Tidsskr Nor Laegeforen; 1975 Sep; 95(26):1485-9. PubMed ID: 1179363
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiple sclerosis: an immunologic perspective.
    Cui JY
    Phys Med Rehabil Clin N Am; 2005 May; 16(2):351-8. PubMed ID: 15893676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reply to "'Thinking without thinking' about natalizumab and PML".
    Houff S; Berger JR
    J Neurol Sci; 2008 Jan; 264(1-2):198-9; author reply 199. PubMed ID: 17936798
    [No Abstract]   [Full Text] [Related]  

  • 6. Species specialization in cytokine biology: is interleukin-4 central to the T(H)1-T(H)2 paradigm in swine?
    Murtaugh MP; Johnson CR; Xiao Z; Scamurra RW; Zhou Y
    Dev Comp Immunol; 2009 Mar; 33(3):344-52. PubMed ID: 18761033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocyte adherence to myelinated tissue in multiple sclerosis.
    Dore-Duffy P; Goertz V; Rothman BL
    J Clin Invest; 1980 Oct; 66(4):843-6. PubMed ID: 6968323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Special issue on multiple sclerosis.
    Bähr M
    Exp Neurol; 2010 Sep; 225(1):1. PubMed ID: 20599978
    [No Abstract]   [Full Text] [Related]  

  • 9. [Humoral immunity. B lymphocytes; immunoglobulins (structure, diversity, function); clinical practice investigations; concept of humoral immunity deficiency].
    Cogné M
    Rev Prat; 2001 Jan; 51(2):193-202. PubMed ID: 11252947
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiple sclerosis: classification revisited reveals homogeneity and recapitulation.
    Raine CS
    Ann Neurol; 2008 Jan; 63(1):1-3. PubMed ID: 18232014
    [No Abstract]   [Full Text] [Related]  

  • 11. Human mast cells stimulate activated T cells: implications for multiple sclerosis.
    Theoharides TC; Kempuraj D; Kourelis T; Manola A
    Ann N Y Acad Sci; 2008 Nov; 1144():74-82. PubMed ID: 19076366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of genetic factors on cell-mediated and humoral immunity in multiple sclerosis.
    Bernard CC
    Isr J Med Sci; 1989 Dec; 25(12):682-5. PubMed ID: 2693399
    [No Abstract]   [Full Text] [Related]  

  • 13. [Humoral immunity].
    Pasquali JL; Korganow AS
    Rev Prat; 1998 Feb; 48(3):337-42. PubMed ID: 9781085
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of hemosorption in disseminated sclerosis].
    Golovkin VI; Pershin VN; Tulenko AG
    Vrach Delo; 1986 Feb; (2):84-6. PubMed ID: 3486528
    [No Abstract]   [Full Text] [Related]  

  • 15. B cells, antibodies, and tertiary lymphoid tissue in MS brains.
    Stüve O; Eagar TN
    Lancet Neurol; 2008 Sep; 7(9):766-7. PubMed ID: 18702996
    [No Abstract]   [Full Text] [Related]  

  • 16. [The immunology of multiple sclerosis: changing concepts].
    Vermersch P
    Rev Neurol (Paris); 2008 Apr; 164 Spec No 2():F138-46. PubMed ID: 18680832
    [No Abstract]   [Full Text] [Related]  

  • 17. [Damage also to nerve cells].
    Krankenpfl J; 2005; 43(7-10):236. PubMed ID: 16515306
    [No Abstract]   [Full Text] [Related]  

  • 18. The gray aspects of white matter disease in multiple sclerosis.
    Steinman L
    Proc Natl Acad Sci U S A; 2009 May; 106(20):8083-4. PubMed ID: 19451620
    [No Abstract]   [Full Text] [Related]  

  • 19. The immunology of multiple sclerosis: disease mechanisms and therapeutic targets.
    Holmøy T
    Minerva Med; 2008 Apr; 99(2):119-40. PubMed ID: 18431322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?
    Bar-Or A; Oger J; Gibbs E; Niino M; Aziz T; Renoux C; Alatab S; Shi FD; Campagnolo D; Jalili F; Rhodes S; Yamashita T; Fan B; Freedman MS; Panitch H; Arnold DL; Vollmer T
    Mult Scler; 2009 Aug; 15(8):959-64. PubMed ID: 19667022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.